Print Page
April 28, 2021 | By S&H
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit
Amgen v. Sanofi and Regeneron – Enablement and the In re Wands Factors
On February 11, 2021, the Court of Appeals for the Federal Circuit (“Federal Circuit”) affirmed a district court’s judgment as a matter of law (“JMOL”) that Amgen’s asserted claims to binding affinity of antibodies were invalid for lack of enablement, holding that undue experimentation would be required to practice the […]
April 28, 2021 | By Gene M. Garner II | An Nguyen
Posted in: S&H IP Blog | U.S. Supreme Court
Posted in: S&H IP Blog | U.S. Supreme Court
United States v. Arthrex Inc. – Constitutionality of PTAB Judge Appointments
A recent case between two medical device companies raised the question of the constitutionality of the method in which Patent Trial and Appeal Board (PTAB) judges are appointed. PTAB judges are administrative patent judges who examine patents whose validity is questioned and hear appeals from patentees whose patent applications have […]
Staas & Halsey LLP Winter Newsletter 2021
Please choose article to Read More on: U.S. SUPREME COURT 1 – Google LLC vs. Oracle America, Inc. ”“ U.S. copyright protection for software interfaces U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT 1 – Amgen Inc. v Sanofi, Aventisub LLC ”“ CAFC heard argument that may influence COVID-19 drug […]
Since 1971, we have provided clients with technical expertise and intellectual property protection.